Skip to main content
Year archive

Vivesto — 2011 filings

All 48 regulatory filings released by Vivesto (VIVE) in 2011, sourced directly from the official regulator.

48 Filings
2011 Period
2011 filings (48)
Filing Released Lang
Interim / Quarterly Report 2011
Interim / Quarterly Report H2 2011
2011-12-08 Swedish
Major Shareholding Notification 2011
Major Shareholding Notification
2011-11-04 English
Major Shareholding Notification 2011
Major Shareholding Notification
2011-11-01 English
Publication of change in the total number of shares and votes in Oasmia
Declaration of Voting Results & Voting Rights Announcements
2011-10-31 English
Offentliggörande av förändring i det totala antalet aktier och röster i Oasmia
Share Issue/Capital Change
2011-10-31 Swedish
Major Shareholding Notification 2011
Major Shareholding Notification
2011-10-26 English
Declaration of Voting Results & Voting Rights Announcements 2011
Declaration of Voting Results & Voting Rights Announcements
2011-10-25 English
Directed new share issue successfully completed - nxt2b new major shareholder
Share Issue/Capital Change
2011-10-25 English
Riktad nyemission genomförd - nxt2b ny stor aktieägare
Capital/Financing Update
2011-10-25 Swedish
Enrolment complete in Phase III study with Paclical®
Regulatory Filings
2011-10-03 English
Rekryteringen klar för fas III-studien med Paclical®
Regulatory Filings
2011-10-03 Swedish
Kommuniké från Årsstämma 2011
AGM Information
2011-09-30 Swedish
Communiqué from Annual General Meeting 2011
AGM Information
2011-09-30 English
Interim / Quarterly Report 2011
Interim / Quarterly Report Q3 2011
2011-09-08 Swedish
Kallelse till Årsstämma 2011
AGM Information
2011-08-31 Swedish
Notice of Annual General Meeting 2011
AGM Information
2011-08-31 English
Corporate Governance report Oasmia Pharmaceutical AB
Governance Information
2011-08-25 English
Oasmia publicerar bolagsstyrningsrapport för räkenskapsåret 2010/2011
Governance Information
2011-08-25 Swedish
Annual Report 2011
Annual Report FY 2011
2011-08-25 Swedish
Annual Report 2011
Annual Report FY 2011
2011-08-25 English
Oasmia och Orion avslutar gemensamt samarbetet för Paclical®
M&A Activity
2011-08-03 Swedish
Oasmia and Orion Corporation jointly end Paclical® agreement
Regulatory Filings
2011-08-03 English
Positive Phase III result from the interim analysis of the study in ovarian cancer with Paclical®
Legal Proceedings Report
2011-08-01 English
Positiva fas III-resultat från interimsanalys av studien på äggstockscancer med Paclical®
Regulatory Filings
2011-08-01 Swedish
FDA grants Paccal® Vet Minor Use designation for squamous cell carcinoma
Regulatory Filings
2011-06-13 English
FDA beviljar Paccal® Vet MUMS-status för skivepitelcancer
Regulatory Filings
2011-06-13 Swedish
Interim / Quarterly Report 2011
Interim / Quarterly Report FY 2011
2011-06-10 Swedish
Audit Report / Information 2011
Audit Report / Information FY 2011
2011-06-10 English
Oasmia Pharmaceutical AB: Clinical study with Doxophos(R) Vet approved
Regulatory Filings
2011-06-09 English
Clinical study with Doxophos® Vet approved
Legal Proceedings Report
2011-06-09 English
Klinisk studie med Doxophos® Vet godkänd
Regulatory Filings
2011-06-09 Swedish
Oasmia Pharmaceutical AB: Oasmia Pharmaceutical AB, Sweden and Medison Pharma, Israel announce license and distribution agreement for Paclical(R) in Israel and Turkey
M&A Activity
2011-05-12 English
Oasmia Pharmaceutical AB och Medison Pharma tecknar licensavtal för Paclical® i Israel och Turkiet
M&A Activity
2011-05-12 Swedish
Oasmia Pharmaceutical AB, Sweden and Medison Pharma, Israel announce license and distribution agreement for Paclical® in Israel and Turkey
Regulatory Filings
2011-05-12 English
Interim / Quarterly Report 2011
Interim / Quarterly Report 9M 2011
2011-03-09 Swedish
Interim / Quarterly Report 2011
Interim / Quarterly Report H2 2011
2011-03-09 English
Bakgrund och fakta med anledning av beskyllningar i medier
Legal Proceedings Report
2011-03-08 Swedish
Oasmia har tecknat avtal med Baxter Oncology för framtida kommersiell produktion
M&A Activity
2011-03-02 Swedish
Oasmia Pharmaceutical AB announces agreement with Baxter Oncology GmbH for large scale commercial manufacturing
Regulatory Filings
2011-03-02 English
Oasmia Pharmaceutical AB: Bjorn Bjornsson new Chairman of the Board of Oasmia Pharmaceutical AB
Board/Management Information
2011-02-08 English
Björn Björnsson ny ordförande i Oasmia Pharmaceutical AB
Board/Management Information
2011-02-08 Swedish
Ticker: Clarification regarding Oasmia SA
Legal Proceedings Report
2011-02-04 English
Ticker: Förtydligande angående Oasmia SA
Board/Management Information
2011-02-03 Swedish
Oasmia Pharmaceutical AB listas på Frankfurt-börsen
Capital/Financing Update
2011-01-21 Swedish
Oasmia Pharmaceutical AB: Oasmia Pharmaceutical's application for listing on Frankfurt Stock Exchange approved
Regulatory Filings
2011-01-21 English
Oasmia Pharmaceutical AB: Oasmia Pharmaceutical AB, Schweden, stellt Antrag auf Listing an Frankfurter Borse
Delisting Announcement
2011-01-18 German
Oasmia Pharmaceutical AB, Sweden has applied for listing at Frankfurt Stock Exchange (DAX).
Capital/Financing Update
2011-01-18 English
Oasmia Pharmaceutical AB har ansökt om notering vid Frankfurt Stock Exchange (DAX).
Regulatory Filings
2011-01-18 Swedish